# 2026-08586: ANI Pharma Applies for Levorphanol Bulk Production

2026-08586, Bulk Manufacturer of Controlled Substances Application: ANI Pharmaceuticals Inc., is a Federal Register notice from Justice Department, Drug Enforcement Administration published 2026-05-04, effective Registered bulk manufacturers of the affected basic class(es), and applicants, therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before July 6, 2026. Such persons may also file a written request for a hearing on the application on or before July 6, 2026. (as of 2026-06-08).

- Canonical: https://policyrisk.com/federal-register/2026-08586
- As of: 2026-06-08
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2026-08586
- Title: Bulk Manufacturer of Controlled Substances Application: ANI Pharmaceuticals Inc.
- Type: Notice
- Agencies: Justice Department; Drug Enforcement Administration
- Citation: 91 FR 24008
- Published: 2026-05-04
- Effective: Registered bulk manufacturers of the affected basic class(es), and applicants, therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before July 6, 2026. Such persons may also file a written request for a hearing on the application on or before July 6, 2026.
- Comments close: 2026-07-06
- Significant: no
- Touches household money: no
- Regulation identifier numbers: none
- Last updated: 2026-06-08

## In one line

ANI Pharma Applies for Levorphanol Bulk Production

## Summary

ANI Pharmaceuticals wants to make a big batch of a strong medicine called Levorphanol, which is a controlled substance. This affects people in the drug manufacturing and regulation world, and the public can share their thoughts or ask for a hearing by July 6, 2026. If approved, ANI will help develop new medicines, but no other activities with this drug are allowed under this registration.

## Abstract

ANI Pharmaceuticals Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

## Effects PRIA read

No economic effects identified for this document.

## Related documents

- [2026-11526](https://policyrisk.com/federal-register/2026-11526): Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 201…, 2026-06-09
- [2026-10128](https://policyrisk.com/federal-register/2026-10128): Revision of Applications for Manufacturing and Procurement Quotas, 2026-05-20
- [2025-05007](https://policyrisk.com/federal-register/2025-05007): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-03-24
- [2025-02793](https://policyrisk.com/federal-register/2025-02793): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-02-19
- [2026-22843](https://policyrisk.com/federal-register/2026-22843): Proposed Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ep…, 2026-11-10
- [2026-22842](https://policyrisk.com/federal-register/2026-22842): Adjustment to the 2026 Aggregate Production Quota for d,l-Amphetamine, d-Amphetamine (for Sale), Hydromorphone and Methylphenidate (for Sal…, 2026-11-10

## Sources
- [2026-08586 on federalregister.gov](https://www.federalregister.gov/documents/2026/05/04/2026-08586/bulk-manufacturer-of-controlled-substances-application-ani-pharmaceuticals-inc)
- [2026-08586 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2026-05-04/pdf/2026-08586.pdf)

## Related
- [Previous: 2026-08585, Bulk Manufacturer of Controlled Substances Application: Patheon Pharmaceuticals…](https://policyrisk.com/federal-register/2026-08585)
- [Next: 2026-08587, Importer of Controlled Substances Application: ANI Pharmaceuticals Inc.](https://policyrisk.com/federal-register/2026-08587)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2026-08586 (as of 2026-06-08).
